TCBP early but an alpha alreadyLooking good at 2.48 after a pullback intraday. It was a gap up but pulled back. Tight stop is needed, just incase
Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−7.34 MUSD
About TC BioPharm (Holdings) plc
Sector
Industry
CEO
Bryan Kobel
Website
Headquarters
Motherwell
Employees (FY)
41
Founded
2013
FIGI
BBG0136BRF62
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
